×
ADVERTISEMENT

bevacizumab

Third Biosimilar to Bevacizumab Approved

The FDA approved bevacizumab-maly (Alymsys, Amneal Pharmaceuticals), a biosimilar to bevacizumab (Avastin, ...

APRIL 19, 2022

FDA Approves Avastin Plus Chemo for Certain Women With Advanced Ovarian Cancer

The FDA granted a new indication for Avastin in combination with chemotherapy, followed by Avastin as a single ...

JUNE 14, 2018

FDA Gives Full Approval to Avastin for Recurrent GBM

The FDA has granted full approval for bevacizumab (Avastin, Genentech) for the treatment of adults with ...

DECEMBER 7, 2017

Load more